METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat esophageal cancer
Disease control OngoingThis early-stage trial tested a drug called adavosertib combined with radiation for people with advanced esophageal or stomach cancer that cannot be removed by surgery. The goal was to find the safest dose and see how well the combination works. Only 4 people took part, so result…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Engineered immune cells target brain tumors in early trial
Disease control OngoingThis early-phase study tests a new treatment called HER2-CAR T cells for people with HER2-positive cancers that have spread to the brain or its lining. The treatment involves taking the patient's own immune cells, modifying them to recognize and attack HER2-positive cancer cells,…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:47 UTC